Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
191.69
-6.64 (-3.35%)
Feb 5, 2026, 4:00 PM EST - Market closed
Ligand Pharmaceuticals Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$243.50
Upside
+27.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $234 → $235 | Buy | Maintains | $234 → $235 | +22.59% | Dec 10, 2025 |
| Stifel | Stifel | Strong Buy Maintains $220 → $230 | Strong Buy | Maintains | $220 → $230 | +19.99% | Dec 10, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $270 | Strong Buy | Initiates | $270 | +40.85% | Dec 9, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $185 → $234 | Buy | Maintains | $185 → $234 | +22.07% | Nov 10, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $250 → $275 | Buy | Maintains | $250 → $275 | +43.46% | Nov 7, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $175 → $220 | Strong Buy | Maintains | $175 → $220 | +14.77% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $206 → $231 | Strong Buy | Maintains | $206 → $231 | +20.51% | Nov 6, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $190 → $250 | Buy | Maintains | $190 → $250 | +30.42% | Nov 3, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $167 → $190 | Buy | Maintains | $167 → $190 | -0.88% | Sep 3, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $160 → $175 | Strong Buy | Maintains | $160 → $175 | -8.71% | Sep 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $157 → $206 | Strong Buy | Maintains | $157 → $206 | +7.47% | Aug 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $155 → $185 | Buy | Maintains | $155 → $185 | -3.49% | Aug 8, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $162 → $167 | Buy | Maintains | $162 → $167 | -12.88% | Aug 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $145 → $162 | Buy | Maintains | $145 → $162 | -15.49% | Jul 30, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $142 → $145 | Buy | Maintains | $142 → $145 | -24.36% | May 9, 2025 |
| Stifel | Stifel | Strong Buy Initiates $143 | Strong Buy | Initiates | $143 | -25.40% | Apr 10, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.